These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5784248)

  • 1. [Action of dihydroergotamine used alone in prevention of migraine (apropos of 80 cases)].
    Girard M
    J Med Lyon; 1969 Mar; 50(160):371-97. PubMed ID: 5784248
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of migraine.
    Drug Ther Bull; 1981 Aug; 19(18):69-71. PubMed ID: 7261908
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dihydroergotamine and flunarizine in the prevention of migraine. A comparative double-blind study].
    Langohr HD; Reinecke M; Gerber WD; Mangold R
    Fortschr Med; 1988 Jan; 106(2):65-6, 69-70. PubMed ID: 3278960
    [No Abstract]   [Full Text] [Related]  

  • 4. [Migraine prevention with dihydroergotamine].
    Heuser B; Middendorf E
    Fortschr Med; 1985 Nov; 103(41):966-70. PubMed ID: 3905548
    [No Abstract]   [Full Text] [Related]  

  • 5. Migraine: a series of 38 patients treated with ergotamine tablets.
    Unger L; Cristol JL
    Med Times; 1971 Dec; 99(12):97-102. PubMed ID: 5160898
    [No Abstract]   [Full Text] [Related]  

  • 6. [Transient global amnesia following the use of ergots in the treatment of migraine].
    Gil-Martínez T; Galiano R
    Rev Neurol; 2004 Nov 16-30; 39(10):929-31. PubMed ID: 15573308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of migraine.
    Practitioner; 1971 Apr; 206(234):551-4. PubMed ID: 4930722
    [No Abstract]   [Full Text] [Related]  

  • 8. [Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
    Ferrari MD; Haan J; Bax WA; van Coevorden RS; Timmerman H; Meijler WJ
    Ned Tijdschr Geneeskd; 1993 Apr; 137(17):846-50. PubMed ID: 8387648
    [No Abstract]   [Full Text] [Related]  

  • 9. [Unjustified equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
    Van Mil JW
    Ned Tijdschr Geneeskd; 1993 Jun; 137(24):1213-4. PubMed ID: 8391659
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of migraine].
    Titus F
    Rev Neurol; 1997 Feb; 25(138):295-300. PubMed ID: 9147762
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of migraine with retard dihydroergotamine. Results of a multicenter study in 643 patients].
    Wörz R
    Fortschr Med; 1986 Nov; 104(43):838-42. PubMed ID: 3542767
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug management of adult vascular headaches (migraine and cluster headache): Part I--Treatment of the acute attack.
    Damasio H
    Iowa Med; 1984 Nov; 74(11):490-2. PubMed ID: 6511281
    [No Abstract]   [Full Text] [Related]  

  • 13. History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.
    Tfelt-Hansen PC; Koehler PJ
    Cephalalgia; 2008 Aug; 28(8):877-86. PubMed ID: 18460007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of the acute migraine attack].
    Titus F
    Rev Neurol; 1995; 23 Suppl 2():S203-7. PubMed ID: 7497289
    [No Abstract]   [Full Text] [Related]  

  • 15. Appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine: current perspectives.
    Young WB
    Headache; 1997; 37 Suppl 1():S42-5. PubMed ID: 9009473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MY 25, a peroral prophylactic for migraine].
    Strunge P
    Ugeskr Laeger; 1971 Jun; 133(25):1209-13. PubMed ID: 5560739
    [No Abstract]   [Full Text] [Related]  

  • 17. [Headache (1): migraine].
    Lundberg PO
    Lakartidningen; 1970 Oct; 67(43):4946-61. PubMed ID: 5477785
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic availability of ergotamine tartrate in continuous medication.
    Myllylä VV; Ala-Hurula V; Arvela P; Kärki N; Hokkanen E
    Ups J Med Sci Suppl; 1980; 31():20-2. PubMed ID: 6935854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practice parameter: appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Neurology; 1995 Mar; 45(3 Pt 1):585-7. PubMed ID: 7898723
    [No Abstract]   [Full Text] [Related]  

  • 20. Headache.
    Raskin NH
    West J Med; 1994 Sep; 161(3):299-302. PubMed ID: 7975570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.